Important Safety Information on COPAXONE (glatiramer acetate) and the Risk of Anaphylactic Reactions Which May Occur at Any Time Following Initiation of Treatment
New safety information - Product safety - Adverse reaction
Read the official notice →- Date
- 2025-08-21
- Country
- Canada
- Product
- COPAXONE (glatiramer acetate)
- Category
- Other
- Source
- Health Canada
Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the brand, model, batch number and pictures against the official notice.
- If yours matches, stop using it and keep it away from children.
- Follow the remedy in the notice: a refund, repair or replacement from the seller or maker. Many recalls also apply to items bought online.
General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.
Other other recalls in Canada
- 2025-08-25
CA- CA
Important Safety Information on CRYSVITA (burosumab) and the Risk of Severe Hypercalcemia in Patients with Tertiary Hyperparathyroidism
New safety information - Product safety
Health CanadaOfficial notice → - 2025-08-21
- CA
Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis
Product safety - New safety information
Health CanadaOfficial notice → - 2025-08-08
- CA
Fake (counterfeit) Cialis and Viagra seized from Toronto, Pickering, and Brantford stores may pose serious health risks
Product safety - Unauthorized product
Health CanadaOfficial notice → - 2025-08-07
- CA
- 2025-08-06
- CA
Total Saddle Fit Shoulder Relief Saddle Cinches recalled due to Fall and Injury Hazards
Fall hazard - Injury hazard
Health CanadaOfficial notice →